Literature DB >> 12427781

Protective role of appendicectomy on onset and severity of ulcerative colitis and Crohn's disease.

G L Radford-Smith1, J E Edwards, D M Purdie, N Pandeya, M Watson, N G Martin, A Green, B Newman, T H J Florin.   

Abstract

BACKGROUND AND AIMS: Recent studies on appendicectomy rates in ulcerative colitis and Crohn's disease have generally not addressed the effect of appendicectomy on disease characteristics. The aims of this study were to compare appendicectomy rates in Australian inflammatory bowel disease patients and matched controls, and to evaluate the effect of prior appendicectomy on disease characteristics.
METHODS: Patients were ascertained from the Brisbane Inflammatory Bowel Disease database. Controls matched for age and sex were randomly selected from the Australian Twin Registry. Disease characteristics included age at diagnosis, disease site, need for immunosuppression, and intestinal resection.
RESULTS: The study confirmed the significant negative association between appendicectomy and ulcerative colitis (odds ratio (OR) 0.23, 95% confidence interval (CI) 0.14-0.38; p<0.0001) and found a similar result for Crohn's disease once the bias of appendicectomy at diagnosis was addressed (OR 0.34, 95% CI 0.23-0.51; p<0.0001). Prior appendicectomy delayed age of presentation for both diseases and was statistically significant for Crohn's disease (p=0.02). In ulcerative colitis, patients with prior appendicectomy had clinically milder disease with reduced requirement for immunosuppression (OR 0.15, 95% CI 0.02-1.15; p=0.04) and proctocolectomy (p=0.02).
CONCLUSIONS: Compared with patients without prior appendicectomy, appendicectomy before diagnosis delays disease onset in ulcerative colitis and Crohn's disease and gives rise to a milder disease phenotype in ulcerative colitis.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12427781      PMCID: PMC1773455          DOI: 10.1136/gut.51.6.808

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  40 in total

Review 1.  Are the inflammatory bowel diseases autoimmune disorders?

Authors:  J Snook
Journal:  Gut       Date:  1990-09       Impact factor: 23.059

2.  Appendectomy in Australian twins.

Authors:  D L Duffy; N G Martin; J D Mathews
Journal:  Am J Hum Genet       Date:  1990-09       Impact factor: 11.025

3.  Appendectomy and the risk of developing ulcerative colitis or Crohn's disease: results of a large case-control study. South Limburg Inflammatory Bowel Disease Study Group.

Authors:  M G Russel; E Dorant; R J Brummer; M A van de Kruijs; J W Muris; J M Bergers; J Goedhard; R W Stockbrügger
Journal:  Gastroenterology       Date:  1997-08       Impact factor: 22.682

4.  Classification of inflammatory bowel disease.

Authors:  J E Lennard-Jones
Journal:  Scand J Gastroenterol Suppl       Date:  1989

5.  Prevalence of appendectomy among ulcerative colitis patients and their relatives.

Authors:  D Lopez-Ramos; R Gabriel; J Cantero-Perona; R Moreno-Otero; E A Jones; J Maté-Jimenez
Journal:  Eur J Gastroenterol Hepatol       Date:  2001-10       Impact factor: 2.566

6.  Expression of human immunoglobulin G subclasses in inflammatory bowel disease.

Authors:  R P MacDermott; M H Nahm
Journal:  Gastroenterology       Date:  1987-11       Impact factor: 22.682

7.  Appendectomy protects against ulcerative colitis.

Authors:  P Rutgeerts; G D'Haens; M Hiele; K Geboes; G Vantrappen
Journal:  Gastroenterology       Date:  1994-05       Impact factor: 22.682

8.  Appendectomy and tonsillectomy in patients with inflammatory bowel disease.

Authors:  J E Smithson; G Radford-Smith; G P Jewell
Journal:  J Clin Gastroenterol       Date:  1995-12       Impact factor: 3.062

9.  Role of appendectomy and tonsillectomy in pathogenesis of ulcerative colitis.

Authors:  A Minocha; C A Raczkowski
Journal:  Dig Dis Sci       Date:  1997-07       Impact factor: 3.199

10.  Childhood factors in ulcerative colitis and Crohn's disease. An international cooperative study.

Authors:  T Gilat; D Hacohen; P Lilos; M J Langman
Journal:  Scand J Gastroenterol       Date:  1987-10       Impact factor: 2.423

View more
  60 in total

1.  Appendix redux.

Authors:  D B Sachar
Journal:  Gut       Date:  2002-12       Impact factor: 23.059

2.  Predictors of aggressive inflammatory bowel disease.

Authors:  Andres J Yarur; Sebastian G Strobel; Amar R Deshpande; Maria T Abreu
Journal:  Gastroenterol Hepatol (N Y)       Date:  2011-10

3.  Pre-colectomy appendectomy and risk for Crohn's disease in patients with ileal pouch-anal anastomosis.

Authors:  Zhaoxiu Liu; Haiyan Lu; Ravi P Kiran; Runzhou Ni; Feza H Remzi; Bo Shen
Journal:  J Gastrointest Surg       Date:  2012-04-24       Impact factor: 3.452

Review 4.  The epidemiology and risk factors of inflammatory bowel disease.

Authors:  Yulan Ye; Zhi Pang; Weichang Chen; Songwen Ju; Chunli Zhou
Journal:  Int J Clin Exp Med       Date:  2015-12-15

Review 5.  Gastrointestinal diseases and their oro-dental manifestations: Part 2: Ulcerative colitis.

Authors:  C X W Tan; H S Brand; N K H de Boer; T Forouzanfar
Journal:  Br Dent J       Date:  2017-01-13       Impact factor: 1.626

Review 6.  Recent advances in understanding ulcerative colitis.

Authors:  Antonio Di Sabatino; Paolo Biancheri; Laura Rovedatti; Thomas Thornton Macdonald; Gino Roberto Corazza
Journal:  Intern Emerg Med       Date:  2011-11-09       Impact factor: 3.397

7.  Appendix is a priming site in the development of ulcerative colitis.

Authors:  Mitsunobu Matsushita; Hiroshi Takakuwa; Yuji Matsubayashi; Akiyoshi Nishio; Susumu Ikehara; Kazuichi Okazaki
Journal:  World J Gastroenterol       Date:  2005-08-21       Impact factor: 5.742

8.  Oral treatment with genistein reduces the expression of molecular and biochemical markers of inflammation in a rat model of chronic TNBS-induced colitis.

Authors:  Jan Seibel; Almut F Molzberger; Torsten Hertrampf; Ute Laudenbach-Leschowski; Patrick Diel
Journal:  Eur J Nutr       Date:  2009-02-21       Impact factor: 5.614

9.  Epstein-Barr virus is related with 5-aminosalicylic acid, tonsillectomy, and CD19(+) cells in Crohn's disease.

Authors:  Juan C Andreu-Ballester; Rafael Gil-Borrás; Carlos García-Ballesteros; Ignacio Catalán-Serra; Victoria Amigo; Virgina Fernández-Fígares; Carmen Cuéllar
Journal:  World J Gastroenterol       Date:  2015-04-21       Impact factor: 5.742

Review 10.  Appendectomy does not decrease the risk of future colectomy in UC: results from a large cohort and meta-analysis.

Authors:  Alyssa Parian; Berkeley Limketkai; Joyce Koh; Steven R Brant; Alain Bitton; Judy H Cho; Richard H Duerr; Dermot P McGovern; Deborah D Proctor; Miguel D Regueiro; John D Rioux; Phil Schumm; Kent D Taylor; Mark S Silverberg; A Hillary Steinhart; Ruben Hernaez; Mark Lazarev
Journal:  Gut       Date:  2016-04-13       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.